Tatjana Prenđa Trupec
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tatjana Prenđa Trupec has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anna-Lena Frey
University of Reading
2 shared publications - Antanas Montvila
Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, Kaunas, Lithuania
2 shared publications - Carla Toro
Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
2 shared publications - Carme Pratdepàdua Bufill
Fundació TIC Salut Social, Ministry of Health, Government of Catalonia, Aragó 330-332, Barcelona, 08009, Spain, 34 667162080
2 shared publications - Charles McCay
Ramsey Systems Ltd, Shrewsbury, United Kingdom
2 shared publications - Giuseppe D'Avenio
Centro Nazionale Tecnologie Innovative in Sanità Pubblica, Istituto Superiore di Sanità, 00161 Rome, Italy
2 shared publications
Latest Publications
- Open Access
- 26 May 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13 (1) , e57474
Preferences and Willingness to Pay for Health App Assessments Among Health Care Stakeholders: Discrete Choice Experiment
Background: The adoption of high-quality health apps has been slow, despite the myriad benefits associated with their use. This is partly due to concerns regarding the effectiveness, safety, and data privacy of such apps. Quality assessments with robust and transparent criteria can address these concerns and, thereby, encourage the use of high-quality apps. However, a major challenge for such assessments is reaching a scale at which a substantial proportion of the more than 350,000 available health apps can be evaluated. Objective: To support the scaling of health app quality assessments, this study aimed to examine the preferences and willingness to pay for assessments with different value propositions among potential customers. Methods: We conducted 2 discrete choice experiments: one with 41 health app developers and another with 46 health system representatives (from health care institutions, authorities, and insurers) from across Europe. Mixed logit models were applied to examine the impact of assessment attributes on participants’ choices as well as to calculate marginal willingness to pay and predicted assessment uptake. Results: Among health app developers, the attributes with the largest impact on assessment choices were the associated clinical care uptake (integration into clinical guidelines and reimbursement or procurement) and cost (purchase price). Increased willingness to use assessed apps and app store integration of assessment results had a moderate impact on choices, while required developer time investment and time until assessment results become available made the smallest contribution. Among health system representatives, increased willingness of clinicians and patients to use evaluated apps had the greatest impact on assessment choices, followed by cost. Time until assessment result availability and the percentage of peers recommending the assessment made a moderate contribution, while reassessment frequency had the smallest impact on choices. On average, health app developers were willing to pay an additional €9020 (95% CI €4968-€13,072) if an assessment facilitates guideline integration and procurement or reimbursement (at the time of data collection, €1=US $1.11), while health system representatives were, on average, willing to pay €7037 (95% CI €4267-€9806) more if an assessment results in a large, rather than a small, increase in willingness to use the evaluated app. The predicted uptake of assessments that offer the preferred values for all attributes was 88.6% among app developers and 91.1% among health system representatives. Conclusions: These findings indicate that, to maximize uptake and willingness to pay among health app developers, it is advisable for assessments to facilitate or enable clinical guideline integration and reimbursement or procurement for high-scoring apps. Assessment scaling thus requires close collaboration with health authorities, health care institutions, and insurers. Furthermore, if health system organizations are targeted as customers, it is essential to provide evidence for the assessment’s impact on patients’ and clinicians’ willingness to use health apps.
- 26 May 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13 (1) , e57474
Open AccessPreferences and Willingness to Pay for Health App Assessments Among Health Care Stakeholders: Discrete Choice Experiment
Background: The adoption of high-quality health apps has been slow, despite the myriad benefits associated with their use. This is partly due to concerns regarding the effectiveness, safety, and data privacy of such apps. Quality assessments with robust and transparent criteria can address these concerns and, thereby, encourage the use of high-quality apps. However, a major challenge for such assessments is reaching a scale at which a substantial proportion of the more than 350,000 available health apps can be evaluated. Objective: To support the scaling of health app quality assessments, this study aimed to examine the preferences and willingness to pay for assessments with different value propositions among potential customers. Methods: We conducted 2 discrete choice experiments: one with 41 health app developers and another with 46 health system representatives (from health care institutions, authorities, and insurers) from across Europe. Mixed logit models were applied to examine the impact of assessment attributes on participants’ choices as well as to calculate marginal willingness to pay and predicted assessment uptake. Results: Among health app developers, the attributes with the largest impact on assessment choices were the associated clinical care uptake (integration into clinical guidelines and reimbursement or procurement) and cost (purchase price). Increased willingness to use assessed apps and app store integration of assessment results had a moderate impact on choices, while required developer time investment and time until assessment results become available made the smallest contribution. Among health system representatives, increased willingness of clinicians and patients to use evaluated apps had the greatest impact on assessment choices, followed by cost. Time until assessment result availability and the percentage of peers recommending the assessment made a moderate contribution, while reassessment frequency had the smallest impact on choices. On average, health app developers were willing to pay an additional €9020 (95% CI €4968-€13,072) if an assessment facilitates guideline integration and procurement or reimbursement (at the time of data collection, €1=US $1.11), while health system representatives were, on average, willing to pay €7037 (95% CI €4267-€9806) more if an assessment results in a large, rather than a small, increase in willingness to use the evaluated app. The predicted uptake of assessments that offer the preferred values for all attributes was 88.6% among app developers and 91.1% among health system representatives. Conclusions: These findings indicate that, to maximize uptake and willingness to pay among health app developers, it is advisable for assessments to facilitate or enable clinical guideline integration and reimbursement or procurement for high-scoring apps. Assessment scaling thus requires close collaboration with health authorities, health care institutions, and insurers. Furthermore, if health system organizations are targeted as customers, it is essential to provide evidence for the assessment’s impact on patients’ and clinicians’ willingness to use health apps.
- 28 March 2025
- Published by IGI Global Scientific Publishing
- p. 135-166
Adoption of Innovative Digital Technologies for Enhancing Health Financing
Innovative technologies such as mobile applications, web platforms, digital payments, blockchain, big data analytics, and artificial intelligence can significantly enhance health financing functions like revenue raising, pooling, and service purchasing. Transformative impact of digital solutions include Kenya's M-TIBA platform, India's Ayushman Bharat Pradhan Mantri Jan Arogya Yojana, which uses a digital Transaction Management System to support the entire patient journey from registration to claims payment, and Estonia's e-invoicing system. Successful implementation requires a robust digital ecosystem encompassing governance, infrastructure, and skilled human resources. This involves establishing dedicated digital health departments, developing regulatory frameworks, and ensuring data security and interoperability. Moreover, it is crucial to address challenges such as technology access inequities and weak health systems to maximize the benefits of digital health financing.
- 28 March 2025
- Published by IGI Global Scientific Publishing
- p. 135-166
Adoption of Innovative Digital Technologies for Enhancing Health Financing
Innovative technologies such as mobile applications, web platforms, digital payments, blockchain, big data analytics, and artificial intelligence can significantly enhance health financing functions like revenue raising, pooling, and service purchasing. Transformative impact of digital solutions include Kenya's M-TIBA platform, India's Ayushman Bharat Pradhan Mantri Jan Arogya Yojana, which uses a digital Transaction Management System to support the entire patient journey from registration to claims payment, and Estonia's e-invoicing system. Successful implementation requires a robust digital ecosystem encompassing governance, infrastructure, and skilled human resources. This involves establishing dedicated digital health departments, developing regulatory frameworks, and ensuring data security and interoperability. Moreover, it is crucial to address challenges such as technology access inequities and weak health systems to maximize the benefits of digital health financing.
- Open Access
- 17 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Preferences and Willingness to Pay for Health App Assessments Among Health Care Stakeholders: Discrete Choice Experiment (Preprint)
BACKGROUND The adoption of high-quality health apps has been slow, despite the myriad benefits associated with their use. This is partly due to concerns regarding the effectiveness, safety, and data privacy of such apps. Quality assessments with robust and transparent criteria can address these concerns and, thereby, encourage the use of high-quality apps. However, a major challenge for such assessments is reaching a scale at which a substantial proportion of the more than 350,000 available health apps can be evaluated. OBJECTIVE To support the scaling of health app quality assessments, this study aimed to examine the preferences and willingness to pay for assessments with different value propositions among potential customers. METHODS We conducted 2 discrete choice experiments: one with 41 health app developers and another with 46 health system representatives (from health care institutions, authorities, and insurers) from across Europe. Mixed logit models were applied to examine the impact of assessment attributes on participants’ choices as well as to calculate marginal willingness to pay and predicted assessment uptake. RESULTS Among health app developers, the attributes with the largest impact on assessment choices were the associated clinical care uptake (integration into clinical guidelines and reimbursement or procurement) and cost (purchase price). Increased willingness to use assessed apps and app store integration of assessment results had a moderate impact on choices, while required developer time investment and time until assessment results become available made the smallest contribution. Among health system representatives, increased willingness of clinicians and patients to use evaluated apps had the greatest impact on assessment choices, followed by cost. Time until assessment result availability and the percentage of peers recommending the assessment made a moderate contribution, while reassessment frequency had the smallest impact on choices. On average, health app developers were willing to pay an additional €9020 (95% CI €4968-€13,072) if an assessment facilitates guideline integration and procurement or reimbursement (at the time of data collection, €1=US $1.11), while health system representatives were, on average, willing to pay €7037 (95% CI €4267-€9806) more if an assessment results in a large, rather than a small, increase in willingness to use the evaluated app. The predicted uptake of assessments that offer the preferred values for all attributes was 88.6% among app developers and 91.1% among health system representatives. CONCLUSIONS These findings indicate that, to maximize uptake and willingness to pay among health app developers, it is advisable for assessments to facilitate or enable clinical guideline integration and reimbursement or procurement for high-scoring apps. Assessment scaling thus requires close collaboration with health authorities, health care institutions, and insurers. Furthermore, if health system organizations are targeted as customers, it is essential to provide evidence for the assessment’s impact on patients’ and clinicians’ willingness to use health apps.
- 17 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPreferences and Willingness to Pay for Health App Assessments Among Health Care Stakeholders: Discrete Choice Experiment (Preprint)
BACKGROUND The adoption of high-quality health apps has been slow, despite the myriad benefits associated with their use. This is partly due to concerns regarding the effectiveness, safety, and data privacy of such apps. Quality assessments with robust and transparent criteria can address these concerns and, thereby, encourage the use of high-quality apps. However, a major challenge for such assessments is reaching a scale at which a substantial proportion of the more than 350,000 available health apps can be evaluated. OBJECTIVE To support the scaling of health app quality assessments, this study aimed to examine the preferences and willingness to pay for assessments with different value propositions among potential customers. METHODS We conducted 2 discrete choice experiments: one with 41 health app developers and another with 46 health system representatives (from health care institutions, authorities, and insurers) from across Europe. Mixed logit models were applied to examine the impact of assessment attributes on participants’ choices as well as to calculate marginal willingness to pay and predicted assessment uptake. RESULTS Among health app developers, the attributes with the largest impact on assessment choices were the associated clinical care uptake (integration into clinical guidelines and reimbursement or procurement) and cost (purchase price). Increased willingness to use assessed apps and app store integration of assessment results had a moderate impact on choices, while required developer time investment and time until assessment results become available made the smallest contribution. Among health system representatives, increased willingness of clinicians and patients to use evaluated apps had the greatest impact on assessment choices, followed by cost. Time until assessment result availability and the percentage of peers recommending the assessment made a moderate contribution, while reassessment frequency had the smallest impact on choices. On average, health app developers were willing to pay an additional €9020 (95% CI €4968-€13,072) if an assessment facilitates guideline integration and procurement or reimbursement (at the time of data collection, €1=US $1.11), while health system representatives were, on average, willing to pay €7037 (95% CI €4267-€9806) more if an assessment results in a large, rather than a small, increase in willingness to use the evaluated app. The predicted uptake of assessments that offer the preferred values for all attributes was 88.6% among app developers and 91.1% among health system representatives. CONCLUSIONS These findings indicate that, to maximize uptake and willingness to pay among health app developers, it is advisable for assessments to facilitate or enable clinical guideline integration and reimbursement or procurement for high-scoring apps. Assessment scaling thus requires close collaboration with health authorities, health care institutions, and insurers. Furthermore, if health system organizations are targeted as customers, it is essential to provide evidence for the assessment’s impact on patients’ and clinicians’ willingness to use health apps.